Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission 
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm 
FDA Pilot Program Eases Rules for Nicotine Pouch Makers 
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals 
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock 
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions 
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off 
Neuralink Expands Brain Implant Trials with 12 Global Patients 
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns 
Thailand Inflation Remains Negative for 10th Straight Month in January 
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient 
Gold and Silver Prices Slide as Dollar Strength and Easing Tensions Weigh on Metals 
A new diagnostic method that ascertains if a person is suffering from Parkinson’s disease or dementia by looking at the manner of walking has been patented.
A new diagnostic technique developed by a St. Mary's Hospital research team in Uijeongbu has been patented and put up for patent registration, which analyses data from an individual's shoes to detect neurological disorders.
Most degenerative brain disorders, such as Parkinson's disease, dementia, and Lou Gehrig's disease, occur at an older age.
Currently, a costly MRI or a PET scan is required for such diagnosis, as well as frequent visits to the hospital.
The new approach, on the other hand, employs a "smart insole" that is placed inside a shoe and collects data from its sensors, which is then analyzed to assess the brain health of the wearer.
The new technique achieved an accuracy of 98.1 percent for the diagnosis of Parkinson's disease, as well as 83.2 percent for differentiating whether an illness is vascular or degenerative.
